Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Neurourol Urodyn. 2023 Aug;42(6):1411-1420. doi: 10.1002/nau.25193. Epub 2023 Apr 25.
This study aimed to investigate the postoperative urinary continence rate and incontinence types compared over time between conventional robot-assisted radical prostatectomy (C-RARP) and Retzius-sparing RARP (RS-RARP).
All 61 cases were selected from the C-RARP and RS-RARP by propensity score matching, and the pad scale, 24-h pad weight test, and International consultation on incontinence questionnaire-short form (ICIQ-SF) were followed-up over time up to 12 months.
The probability of urinary continence per pad scale evaluation differed according to how it was defined: the continence rate 12 months after C-RARP and RS-RARP were 94% and 95% for 1 pad/day, 85% and 92% for 1 security pad/day, 61% and 85% for no pad use, respectively, which were all significantly better with RS-RARP. The results of the 24-h pad weight test were significantly better with RS-RARP at both 3 and 12 months, with median C-RARP versus RS-RARP values of 5 versus 1 g and 2 versus 0 g, respectively. In terms of types of urinary incontinence, the rates of postoperative stress urinary incontinence (SUI) increased in both procedures but to a lesser extent in RS-RARP. Other types of urinary incontinence, such as urge incontinence and terminal dribbling, did not differ significantly before and after surgery and between the two procedures.
Postoperative urinary continence was better with RS-RARP than with C-RARP per all follow-up parameters until 12 months postoperatively. Postoperative SUI was significantly lower with RS-RARP than with C-RARP, which was considered the main reason for better postoperative urinary continence with RS-RARP.
本研究旨在比较传统机器人辅助根治性前列腺切除术(C-RARP)与保留耻骨后间隙的机器人辅助根治性前列腺切除术(RS-RARP)的术后尿控率和尿失禁类型。
通过倾向评分匹配,从 C-RARP 和 RS-RARP 中选择了 61 例患者,随访时间长达 12 个月,随访内容包括尿垫量表、24 小时尿垫称重试验和国际尿失禁咨询问卷-短表(ICIQ-SF)。
根据不同定义,尿垫量表评估的尿控概率存在差异:C-RARP 和 RS-RARP 术后 12 个月 1 片/天的尿控率分别为 94%和 95%,1 安全垫/天的尿控率分别为 85%和 92%,无尿垫使用的尿控率分别为 61%和 85%,RS-RARP 均显著更好。24 小时尿垫称重试验的结果在 3 个月和 12 个月时均显示 RS-RARP 更好,C-RARP 与 RS-RARP 的中位数分别为 5g 和 1g,2g 和 0g。在尿失禁类型方面,两种手术术后压力性尿失禁(SUI)的发生率均增加,但 RS-RARP 发生率增加程度较小。其他类型的尿失禁,如急迫性尿失禁和尿末滴沥,术前与术后以及两种手术之间无显著差异。
在所有随访参数中,RS-RARP 的术后尿控率均优于 C-RARP,直至术后 12 个月。与 C-RARP 相比,RS-RARP 术后 SUI 发生率显著降低,这被认为是 RS-RARP 术后尿控更好的主要原因。